Chronic Kidney Disease Trial, Recruiting NCT07690202 Sponsor: University Hospital, Caen Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07690202
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 18 or older who are cisgender and have not yet gone through menopause
  • People who are being monitored at Caen University Hospital for chronic kidney disease (long-term kidney disease)
  • People who are not currently receiving any kidney replacement treatment, meaning not on dialysis and have not had a kidney transplant
  • People who have been given information about the study and have agreed to take part

Who may not be able to join:

  • People who are not covered by a national health insurance scheme
  • People who are under a legal protection arrangement, such as guardianship or curatorship (where another person or authority has been appointed to help make decisions on their behalf)
  • People who do not have sufficient spoken and written French to understand the study information, take part in interviews, or complete the quality-of-life questionnaire
  • People who are unable to attend in-person appointments at the Centre Universitaire des Maladies Rénales (CUMR) in Caen
  • People who have other significant health conditions, apart from chronic kidney disease, that could affect the study results — for example, conditions that may affect fertility (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Antoine Lanot, MD, University Hospital, Caen

Phone: +33682753772

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Caen
Registry
ClinicalTrials.gov
Start date
30 June 2026
Est. completion
1 August 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Lived experience of chronic kidney disease in women of childbearing age (without renal replacement therapy)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov